Archer Materials is tracking well with the development of the Biochip and 12CQ
We spoke with Simon Ruffell, CTO of Archer Materials (ASX:AXE), about the near term milestones for the development of the Biochip and 12CQ. We also touched on the departure of CEO Couchair as well as the big opportunities in the market for the Biochip.
Check out the research coverage of Archer Materials by Pitt Street Research!
Looking for the Best ASX Semiconductor Stocks to invest in right now?
Check our ASX buy/sell tips
